Vaccines 

Platinum Research Network Vaccine Investigators.png

Platinum Research Network specializes in vaccines studies in all phases, age groups, and health status. While all of our sites conduct clinical trials in multiple therapeutic areas and specialties, all Platinum Investigators and clinical teams are engaged in supporting vaccine studies.

Our sites excel at delivering high quality data and robust enrollment for vaccine clinical trials, at 25 vaccine research centers in the USA and Mexico. Whether you are seeking rapid enrollment for later phase vaccine trials, or paced enrollment for First-in-Human or early phase vaccine studies, our clinical teams are experts at execution. All PRN sites utilize Central IRBs. Learn more about quality assurance standards and recruitment processes!

As of January 2019, 27 Platinum Principal Investigators have initiated 364 vaccine clinical trials, enrolling over 28,000 clinical trials at a rate of 110% of contract goals.


Vaccine Indications

 
  • Anthrax

  • C. Difficile

  • Chikungunya

  • Dengue Fever

  • Ebola

  • Hepatitis

  • HSV-2

  • Herpes Zoster

  • HIV

  • HPV

  • Influenza (Pandemic)

  • Influenza (Seasonal)

  • Japanese Encephalitis

  • Maternal Immunization

  • MMR

  • Meningococcal

  • Norovirus

  • Plague

  • Pneumococcal

  • Rabies

  • RSV

  • Smallpox

  • Smoking Cessation

  • Staphylococcus Aureus

  • TDaP

  • West Nile Virus


Advanced Lab and Pharmacy Capabilities

Vaccine clinical research sites

Platinum Vaccine Sites have optimized local SOPs and processes to accommodate vaccine studies. Our clinical teams have also invested in advanced local pharmacy and lab capabilities. Advanced vaccine capabilities include:

  • Local PBMC Labs

  • Laminar Flow Hoods

  • Institutional Biosafety Committees

  • Genetically Modified Vaccines

  • Multiple Dedicated Pharmacists

  • Experienced Lab Specialists

Patient Recruitment and Retention

Each Platinum Vaccine site is supported by dedicated recruitment teams that work with our investigators to recruit qualified patients from their private practices. Large databases and IRB-approved marketing materials are utilized to optimize enrollment. Our vaccine experience includes patients of all ages including pediatrics (31%), Adult (40%), and Older Adults (29%). Our retention average retention rate is 96.7% across all projects, facilitated by ongoing visit reminders and ongoing subject engagement until your final data point is captured.

Focus on Influenza

Platinum investigators have initiated 160 influenza vaccine trials in the last 15 years, including 118 seasonal flu vaccine trials, 22 pandemic flu vaccine trials, and 20 off-season flu vaccine trials. As a network, our Principal Investigators and Clinical Teams have unmatched clinical trials experience in the Influenza space, including dozens of flu treatment and diagnostic studies.